Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Tislelizumab in Metastatic Microsatellite Stable Colorectal Carcinoma: NCT07801352 Clinical Landscape Report 2026
9 min read
Tislelizumab in Metastatic Microsatellite Stable Colorectal Carcinoma: NCT07801352 Clinical Landscape Report 2026
16 September 2026
NCT07801352 clinical landscape for Metastatic Microsatellite Stable Colorectal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and d…
Read →
Phenytoin in Squamous cell carcinoma of the oral cavity: NCT07801157 Clinical Landscape Report 2026
9 min read
Phenytoin in Squamous cell carcinoma of the oral cavity: NCT07801157 Clinical Landscape Report 2026
16 September 2026
NCT07801157 clinical landscape for Squamous cell carcinoma of the oral cavity: endpoints, sponsor, phase, geography, readouts, asset context and development…
Read →
DES-1357 in Microsatellite instability-high colorectal cancer: NCT07807800 Clinical Landscape Report 2026
9 min read
DES-1357 in Microsatellite instability-high colorectal cancer: NCT07807800 Clinical Landscape Report 2026
16 September 2026
NCT07807800 clinical landscape for Microsatellite instability-high colorectal cancer: endpoints, sponsor, phase, geography, readouts, asset context and devel…
Read →
MWN105 in Prediabetic State: NCT07804810 Clinical Landscape Report 2026
9 min read
MWN105 in Prediabetic State: NCT07804810 Clinical Landscape Report 2026
16 September 2026
NCT07804810 clinical landscape for Prediabetic State: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
HDM-2017 in Advanced Colorectal Adenocarcinoma: NCT07805551 Clinical Landscape Report 2026
9 min read
HDM-2017 in Advanced Colorectal Adenocarcinoma: NCT07805551 Clinical Landscape Report 2026
16 September 2026
NCT07805551 clinical landscape for Advanced Colorectal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
Read →
DEM301 in Rectal Cancer: NCT07805369 Clinical Landscape Report 2026
9 min read
DEM301 in Rectal Cancer: NCT07805369 Clinical Landscape Report 2026
16 September 2026
NCT07805369 clinical landscape for Rectal Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Mazdutide in Obesity, Abdominal: NCT07803705 Clinical Landscape Report 2026
9 min read
Mazdutide in Obesity, Abdominal: NCT07803705 Clinical Landscape Report 2026
16 September 2026
NCT07803705 clinical landscape for Obesity, Abdominal: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
177Lu-FAP-VG11 in Advanced Malignant Solid Neoplasm: NCT07808177 Clinical Landscape Report 2026
9 min read
177Lu-FAP-VG11 in Advanced Malignant Solid Neoplasm: NCT07808177 Clinical Landscape Report 2026
16 September 2026
NCT07808177 clinical landscape for Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
Read →
MWN-109 in Weight Loss: NCT07804797 Clinical Landscape Report 2026
9 min read
MWN-109 in Weight Loss: NCT07804797 Clinical Landscape Report 2026
16 September 2026
NCT07804797 clinical landscape for Weight Loss: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Acetaminophen in Diabetes Mellitus, Type 1: NCT07803744 Clinical Landscape Report 2026
9 min read
Acetaminophen in Diabetes Mellitus, Type 1: NCT07803744 Clinical Landscape Report 2026
16 September 2026
NCT07803744 clinical landscape for Diabetes Mellitus, Type 1: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
MT-1 in Obesity: NCT07805291 Clinical Landscape Report 2026
9 min read
MT-1 in Obesity: NCT07805291 Clinical Landscape Report 2026
16 September 2026
NCT07805291 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Pembrolizumab in pMMR/​MSS/MSI-L Colon Cancer: NCT07808151 Clinical Landscape Report 2026
9 min read
Pembrolizumab in pMMR/​MSS/MSI-L Colon Cancer: NCT07808151 Clinical Landscape Report 2026
16 September 2026
NCT07808151 clinical landscape for pMMR/​MSS/MSI-L Colon Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →